[HTML][HTML] High versus standard doses of corticosteroids in severe COVID-19: a retrospective cohort study
E Monreal, S Sainz de la Maza… - European Journal of …, 2021 - Springer
Despite the increasing evidence of the benefit of corticosteroids for the treatment of
moderate-severe coronavirus disease 2019 (COVID-19) patients, no data are available …
moderate-severe coronavirus disease 2019 (COVID-19) patients, no data are available …
[PDF][PDF] Effectiveness of glucocorticoid therapy in patients with severe novel coronavirus pneumonia: protocol of a randomized controlled trial
YH Zhou, YY Qin, YQ Lu, F Sun, S Yang, V Harypursat… - Chin Med J, 2020 - med.uminho.pt
Background: At the end of 2019, a novel coronavirus outbreak emerged in Wuhan, China,
and its causative organism has been subsequently designated the 2019 novel coronavirus …
and its causative organism has been subsequently designated the 2019 novel coronavirus …
[HTML][HTML] COVID-19 and COPD: a narrative review of the basic science and clinical outcomes
The 2019 coronavirus disease (COVID-19) pandemic is caused by severe acute respiratory
syndrome-coronavirus-2 (SARS-CoV-2). Clinical outcomes, including mortality, are worse in …
syndrome-coronavirus-2 (SARS-CoV-2). Clinical outcomes, including mortality, are worse in …